2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?
From Aug. 11 through Sept. 15, shares of the troubled Canadian cannabis producer Canopy Growth (NASDAQ: CGC) rocketed 235% higher. Shares of clinical-stage drugmaer Taysha Gene Therapies (NASDAQ: TSHA) soared an even more impressive 345% over the same time frame.
Are there more eye-popping gains up ahead, or is it already too late to buy these volatile stocks? To find out, let's look at the catalysts that drove them higher.
Image source: Getty Images.
Source Fool.com